Literature DB >> 31889008

Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms.

Rebecca Sadler1,2, Julia V Cramer1, Steffanie Heindl1, Sarantos Kostidis3, Dene Betz4, Kielen R Zuurbier4, Bernd H Northoff5, Marieke Heijink3, Mark P Goldberg4, Erik J Plautz4, Stefan Roth1, Rainer Malik1, Martin Dichgans1,2, Lesca M Holdt5, Corinne Benakis1, Martin Giera3, Ann M Stowe4,6, Arthur Liesz7,2.   

Abstract

Recovery after stroke is a multicellular process encompassing neurons, resident immune cells, and brain-invading cells. Stroke alters the gut microbiome, which in turn has considerable impact on stroke outcome. However, the mechanisms underlying gut-brain interaction and implications for long-term recovery are largely elusive. Here, we tested the hypothesis that short-chain fatty acids (SCFAs), key bioactive microbial metabolites, are the missing link along the gut-brain axis and might be able to modulate recovery after experimental stroke. SCFA supplementation in the drinking water of male mice significantly improved recovery of affected limb motor function. Using in vivo wide-field calcium imaging, we observed that SCFAs induced altered contralesional cortex connectivity. This was associated with SCFA-dependent changes in spine and synapse densities. RNA sequencing of the forebrain cortex indicated a potential involvement of microglial cells in contributing to the structural and functional remodeling. Further analyses confirmed a substantial impact of SCFAs on microglial activation, which depended on the recruitment of T cells to the infarcted brain. Our findings identified that microbiota-derived SCFAs modulate poststroke recovery via effects on systemic and brain resident immune cells.SIGNIFICANCE STATEMENT Previous studies have shown a bidirectional communication along the gut-brain axis after stroke. Stroke alters the gut microbiota composition, and in turn, microbiota dysbiosis has a substantial impact on stroke outcome by modulating the immune response. However, until now, the mediators derived from the gut microbiome affecting the gut-immune-brain axis and the molecular mechanisms involved in this process were unknown. Here, we demonstrate that short-chain fatty acids, fermentation products of the gut microbiome, are potent and proregenerative modulators of poststroke neuronal plasticity at various structural levels. We identified that this effect was mediated via circulating lymphocytes on microglial activation. These results identify short-chain fatty acids as a missing link along the gut-brain axis and as a potential therapeutic to improve recovery after stroke.
Copyright © 2020 the authors.

Entities:  

Keywords:  microbiome; neuroinflammation; plasticity; stroke models

Mesh:

Substances:

Year:  2019        PMID: 31889008      PMCID: PMC6989004          DOI: 10.1523/JNEUROSCI.1359-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  79 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke.

Authors:  Jens Neumann; Monika Riek-Burchardt; Josephine Herz; Thorsten R Doeppner; Rebecca König; Heiko Hütten; Eloho Etemire; Linda Männ; Anika Klingberg; Thomas Fischer; Michael W Görtler; Hans-Jochen Heinze; Peter Reichardt; Burkhart Schraven; Dirk M Hermann; Klaus G Reymann; Matthias Gunzer
Journal:  Acta Neuropathol       Date:  2014-11-13       Impact factor: 17.088

3.  Quantifying synapses: an immunocytochemistry-based assay to quantify synapse number.

Authors:  Dominic M Ippolito; Cagla Eroglu
Journal:  J Vis Exp       Date:  2010-11-16       Impact factor: 1.355

Review 4.  Microglia: Dynamic Mediators of Synapse Development and Plasticity.

Authors:  Yuwen Wu; Lasse Dissing-Olesen; Brian A MacVicar; Beth Stevens
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

5.  Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation.

Authors:  Christoph Kleinschnitz; Nicholas Schwab; Peter Kraft; Ina Hagedorn; Angela Dreykluft; Tobias Schwarz; Madeleine Austinat; Bernhard Nieswandt; Heinz Wiendl; Guido Stoll
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

6.  Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke.

Authors:  Joel V Faustino; Xia Wang; Cali E Johnson; Alexander Klibanov; Nikita Derugin; Michael F Wendland; Zinaida S Vexler
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

7.  MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.

Authors:  James T Walsh; Sven Hendrix; Francesco Boato; Igor Smirnov; Jingjing Zheng; John R Lukens; Sachin Gadani; Daniel Hechler; Greta Gölz; Karen Rosenberger; Thomas Kammertöns; Johannes Vogt; Christina Vogelaar; Volker Siffrin; Ali Radjavi; Anthony Fernandez-Castaneda; Alban Gaultier; Ralf Gold; Thirumala-Devi Kanneganti; Robert Nitsch; Frauke Zipp; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

8.  Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing.

Authors:  Qingyun Li; Zuolin Cheng; Lu Zhou; Spyros Darmanis; Norma F Neff; Jennifer Okamoto; Gunsagar Gulati; Mariko L Bennett; Lu O Sun; Laura E Clarke; Julia Marschallinger; Guoqiang Yu; Stephen R Quake; Tony Wyss-Coray; Ben A Barres
Journal:  Neuron       Date:  2018-12-31       Impact factor: 17.173

9.  The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism.

Authors:  Gary Frost; Michelle L Sleeth; Meliz Sahuri-Arisoylu; Blanca Lizarbe; Sebastian Cerdan; Leigh Brody; Jelena Anastasovska; Samar Ghourab; Mohammed Hankir; Shuai Zhang; David Carling; Jonathan R Swann; Glenn Gibson; Alexander Viardot; Douglas Morrison; E Louise Thomas; Jimmy D Bell
Journal:  Nat Commun       Date:  2014-04-29       Impact factor: 14.919

10.  Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway.

Authors:  J Park; M Kim; S G Kang; A H Jannasch; B Cooper; J Patterson; C H Kim
Journal:  Mucosal Immunol       Date:  2014-06-11       Impact factor: 7.313

View more
  56 in total

1.  Adaptive Immune Cells Link Microbial Metabolites to Stroke Recovery.

Authors:  Kathleen Miller-Rhodes
Journal:  J Neurosci       Date:  2020-07-08       Impact factor: 6.167

Review 2.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

3.  Distinct Commensal Bacterial Signature in the Gut Is Associated With Acute and Long-Term Protection From Ischemic Stroke.

Authors:  Corinne Benakis; Carrie Poon; Diane Lane; David Brea; Giulia Sita; Jamie Moore; Michelle Murphy; Gianfranco Racchumi; Costantino Iadecola; Josef Anrather
Journal:  Stroke       Date:  2020-05-14       Impact factor: 7.914

Review 4.  The role of short-chain fatty acids in central nervous system diseases.

Authors:  Yin Dong; Chun Cui
Journal:  Mol Cell Biochem       Date:  2022-05-21       Impact factor: 3.396

Review 5.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

Review 6.  New Insights into Stroke Prevention and Treatment: Gut Microbiome.

Authors:  Linna Zhao; Liji Yang; Yuying Guo; Jie Xiao; Junping Zhang; Shixin Xu
Journal:  Cell Mol Neurobiol       Date:  2021-02-26       Impact factor: 5.046

7.  Chronic T cell proliferation in brains after stroke could interfere with the efficacy of immunotherapies.

Authors:  Steffanie Heindl; Alessio Ricci; Olga Carofiglio; Qihui Zhou; Thomas Arzberger; Nikolett Lenart; Nicolai Franzmeier; Tibor Hortobagyi; Peter T Nelson; Ann M Stowe; Adam Denes; Dieter Edbauer; Arthur Liesz
Journal:  J Exp Med       Date:  2021-05-26       Impact factor: 14.307

Review 8.  Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications.

Authors:  Kazuo Yamashiro; Naohide Kurita; Takao Urabe; Nobutaka Hattori
Journal:  Ann Nutr Metab       Date:  2021-06-09       Impact factor: 3.374

Review 9.  The Gut Ecosystem: A Critical Player in Stroke.

Authors:  Rosa Delgado Jiménez; Corinne Benakis
Journal:  Neuromolecular Med       Date:  2020-11-18       Impact factor: 3.843

Review 10.  Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors.

Authors:  Min-Gyu Gwak; Sun-Young Chang
Journal:  Immune Netw       Date:  2021-06-16       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.